Fig. 1From: Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional studySeroprevalence (adjusted for test performance I) of severe acute respiratory syndrome coronavirus 2 in 16 cities included in the study. This map was created using ArcGIS software by Esri (http://www.esri.com)Back to article page